# Safety Study of Fluconazole in Combination With Flucytosine for the Treatment of Early Cryptococcal Infection

> **NCT01562132** · PHASE2 · TERMINATED · sponsor: **Yale University** · enrollment: 6 (actual)

## Conditions studied

- Cryptococcal Infection Disseminated

## Interventions

- **DRUG:** Flucytosine and fluconazole
- **DRUG:** Fluconazole

## Key facts

- **NCT ID:** NCT01562132
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Stopped in accordance with pre-specified stopping rules for poor recruitment.
- **Last updated:** 2021-09-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01562132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01562132, "Safety Study of Fluconazole in Combination With Flucytosine for the Treatment of Early Cryptococcal Infection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01562132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*